Advance Search
WANG Aijuan, HU Hui, FENG Fang, LUO Sha, YANG Zhishan, HOU Zongnan, YANG Dingquan. Evaluation in effects of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 45-49. DOI: 10.7619/jcmp.20201376
Citation: WANG Aijuan, HU Hui, FENG Fang, LUO Sha, YANG Zhishan, HOU Zongnan, YANG Dingquan. Evaluation in effects of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 45-49. DOI: 10.7619/jcmp.20201376
shu

Evaluation in effects of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia

  • 1.

    Beijing University of Chinese Medicine, Beijing, 100029

  • 2.

    Acupuncture Department, Dong Fang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100078

  • 3.

    Dermatology and Venereal Department, China-Japan Friendship Hospital, Beijing, 100029

More Information
  • Received Date: November 07, 2020
  • Available Online: March 22, 2021
  • Published Date: March 14, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To observe the efficacy and safety of traditional Chinese medicine named Yufa Lotion in the treatment of androgenic alopecia(AGA)by combining the clinical symptoms and trichoscopy system.
      Methods  A total of 56 patients with AGA were randomly divided into observation group(n=39)and control group(n=17) according to lottery method. The observation group was given topical treatment with traditional Chinese medicine named Yufa Lotion, and the control group was given a blank lotion for external use. Both groups used the corresponding lotion continuously for 6 months. The objective indicators(total hair shaft count, hair shaft diameter variation, hair shaft diameter variation rate, scalp inflammation) under trichoscopy in three fixed observation areas (frontal angle, Baihui, and hairpin) before and after 3 months of treatment, clinical subjective symptoms integral (scalp itching, scalp oil secretion, dandruff) were compared, the therapeutic effects of traditional Chinese medicine named Yufa Lotion in the treatment of AGA were analyzed, and the safety of traditional Chinese medicine named Yufa Lotion in the treatment of AGA was evaluated. The incidence of adverse reactions of two groups was compared.
      Results  After treatment, the observation group was significantly better than the control group in terms of variation ratio of hair shaft diameter in left frontal angle forehead, the number of hair shaft diameter variation in Baihui and the variation ratio of hair shaft diameter in Baihui of the observation group were significantly lower than before treatment (P < 0.05). The total number of hair shafts, the number of hair shaft diameter variations, and the hair shaft diameter variation ratio of the left frontal angle, Baihui, and hairpin showed no significant differences compared with those before treatment (P>0.05). After treatment, the effective rates of scalp inflammation, scalp itching and scalp oil secretion in the observation group were higher than those in the control group, and the differences were statistically significant (P < 0.05). There were no adverse reactions in the observation group and the control group during the treatment period.
      Conclusion  The treatment of AGA with traditional Chinese medicine named Yufa Lotion can reduce the number of hair shaft diameter variation, decrease the hair shaft diameter variation ratio, significantly improve scalp inflammation, relieve itching, reduce scalp oil secretion. Besides, it is convenient and safe, and has no obvious adverse reactions.
    • FullText(HTML)
    • References (28)
  • [1]
    中华医学会皮肤性病学分会毛发学组. 中国雄激素性秃发诊疗指南[J]. 临床皮肤科杂志, 2014, 43(3): 182-186. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF201403029.htm
    [2]
    KANTI V, MESSENGER A, DOBOS G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men-short version[J]. J Eur Acad Dermatol Venereol, 2018, 32(1): 11-22. doi: 10.1111/jdv.14624
    [3]
    TSUBOI R, ITAMI S, INUI S, et al. Guidelines for the management of androgenetic alopecia(2010)[J]. J Dermatol, 2012, 39(2): 113-120. doi: 10.1111/j.1346-8138.2011.01361.x
    [4]
    RANGWALA S, RASHID R M. Alopecia: A review of laser and light therapies[J]. Dermatol Online J, 2012, 18(2): 3-3. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM22398224
    [5]
    TRAISH A M. Post-finasteride syndrome: a surmountable challenge for clinicians[J]. Fertil Steril, 2020, 113(1): 21-50. doi: 10.1016/j.fertnstert.2019.11.030
    [6]
    PALLOTTI F, SENOFONTE G, PELLONI M, et al. Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function[J]. Endocrine, 2020, 68(3): 688-694. doi: 10.1007/s12020-020-02219-2
    [7]
    GOTTLIEB T B, KATZ F H, CHIDSEY C A. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine[J]. Circulation, 1972, 45(3): 571-582. doi: 10.1161/01.CIR.45.3.571
    [8]
    赵辨. 中国临床皮肤病学[M]. 南京: 江苏科学技术出版社, 2010: 701-703.
    [9]
    LEE W S, RO B I, HONG S P, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification[J]. J Am Acad Dermatol, 2007, 57(1): 37-46. doi: 10.1016/j.jaad.2006.12.029
    [10]
    MUBKI T, RUDNICKA L, OLSZEWSKA M, et al. Evaluation and diagnosis of the hair loss patient: part Ⅱ. Trichoscopic and laboratory evaluations[J]. J Am Acad Dermatol, 2014, 71(3): 431. e1-431. e11. doi: 10.1016/j.jaad.2014.05.008
    [11]
    NYHOLT D R, GILLESPIE N A, HEATH A C, et al. Genetic basis of male pattern baldness[J]. J Invest Dermatol, 2003, 121(6): 1561-1564. doi: 10.1111/j.1523-1747.2003.12615.x
    [12]
    NORWOOD O T. Male pattern baldness: classification and incidence[J]. South Med J, 1975, 68(11): 1359-1365. doi: 10.1097/00007611-197511000-00009
    [13]
    WANG T L, ZHOU C, SHEN Y W, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities[J]. Br J Dermatol, 2010, 162(4): 843-847. doi: 10.1111/j.1365-2133.2010.09640.x
    [14]
    XU F, SHENG Y Y, MU Z L, et al. Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study[J]. Br J Dermatol, 2009, 160(3): 629-632. doi: 10.1111/j.1365-2133.2008.08909.x
    [15]
    ANITUA E, PINO A, MARTINEZ N, et al. The effect of plasma rich in growth factors on pattern hair loss: a pilot study[J]. Dermatol Surg, 2017, 43(5): 658-670. doi: 10.1097/DSS.0000000000001049
    [16]
    项晶, 苏莹莹, 范建国, 等. 针刺联合低能量激光治疗雄激素性秃发疗效观察[J]. 上海针灸杂志, 2020, 39(2): 188-191. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZJ202002014.htm
    [17]
    刘涛, 李志武, 丁街生, 等. A型肉毒素治疗雄激素源性脱发的临床观察[J]. 中山大学学报: 医学版, 2018, 39(3): 467-471. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK201803023.htm
    [18]
    魏盛, 朱敏刚, 王音, 等. 纳晶微针联合米诺地尔酊治疗男性雄激素性秃发的临床疗效[J]. 中华医学美学美容杂志, 2020, 26(5): 372-374. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhyxmr202005004
    [19]
    占钻, 曹春水, 江娟, 等. 复方丹参注射液对大鼠心肺复苏后凝血功能及血液流变学的影响[J]. 重庆医学, 2019, 48(15): 2524-2527. doi: 10.3969/j.issn.1671-8348.2019.15.002
    [20]
    JIN J, HU Q Y, XU W W, et al. Tanshinone ⅡA attenuates estradiol-induced polycystic ovarian syndrome in mice by ameliorating FSHR expression in the ovary[J]. Exp Ther Med, 2019, 17(5): 3501-3508. http://www.ncbi.nlm.nih.gov/pubmed/30988730
    [21]
    ROH S S, KIM C D, LEE M H, et al. The hair growth promoting effect of Sophora flavescens extract and its molecular regulation[J]. J Dermatol Sci, 2002, 30(1): 43-49. doi: 10.1016/S0923-1811(02)00060-9
    [22]
    姚艺新, 华芳, 洪远林, 等. 川芎药材、饮片及其中成药抗血小板聚集活性的生物检定方法学研究[J]. 中草药, 2017, 48(11): 2249-2254. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201711016.htm
    [23]
    LI Y, HAN M, LIN P, et al. Hair growth promotion activity and its mechanism of Polygonum multiflorum[J]. Evid Based Complement Alternat Med, 2015, 2015: 517901. http://europepmc.org/articles/PMC4534627
    [24]
    张春洪. 生发酊对C57BL/6小鼠毛发生长作用的实验研究[D]. 咸阳: 陕西中医药大学, 2010.
    [25]
    林桂涛, 李荣伟, 耿子凯, 等. 补骨脂水及乙醇提取物雌激素样作用的比较[J]. 中成药, 2016, 38(12): 2688-2691. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201612034.htm
    [26]
    关波, 皇甫俊茹, 徐媛, 等. 不同促透剂对根皮素体外透皮吸收的影响[J]. 中国医药导报, 2019, 16(32): 4-8. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201932002.htm
    [27]
    KIBAR M, AKTAN S, BILGIN M. Scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity[J]. Ann Dermatol, 2014, 26(4): 478-484. doi: 10.5021/ad.2014.26.4.478
    [28]
    徐宇轩, 范卫新. 雄激素受体与雄激素性秃发相关性研究进展[J]. 临床皮肤科杂志, 2019, 48(9): 572-577. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF201909021.htm
    • Related Articles

  • Cited by

    Periodical cited type(2)

    1. 吴瑞英，王磊，杨知山，杨顶权. 雄激素性秃发的治疗进展. 武汉大学学报(医学版). 2023(01): 29-35 .
    2. 夏继宁，项晶. 透骨草-侧柏叶煎剂治疗雄激素性秃发的疗效及对患者焦虑与抑郁水平的影响. 中华全科医学. 2023(01): 123-126 .

    Other cited types(4)

Catalog

    Get Citation
    PDF
    XML
    Article views (495) PDF downloads (36) Cited by(6)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return